Patients for whom consensus supports use of HF-WBI: A comparison of the 2011 and 2018 ASTRO guidelines

These guidelines are intended as a tool to promote appropriately individualized, shared decision-making between physicians and patients. None should be construed as strict or superseding the appropriately informed and considered judgments of individual physicians and patients; therefore, the task force recommends against any quality benchmarks requiring 100% utilization of HF-WBI, even in patients where recommendations for HF-WBI are strong because the distribution of reasonable patient values and preferences would be expected to yield a patient-centered choice for conventionally fractionated WBI in a certain proportion of individual patients.